Wool-Like Hollow Polymeric Nanoparticles for CML Chemo-Combinatorial Therapy

Chronic myeloid leukaemia (CML) is caused by the BCR-ABL oncogene, which encodes the constitutively active BCR-ABL tyrosine kinase. Targeted therapy with tyrosine-kinase inhibitors induces a partial cytogenetic response in most patients. Nanosystems can represent an opportunity for combinatorial the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortese, Barbara, D’Amone, Stefania, Palamà, Ilaria Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027521/
https://www.ncbi.nlm.nih.gov/pubmed/29670043
http://dx.doi.org/10.3390/pharmaceutics10020052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027521/
https://www.ncbi.nlm.nih.gov/pubmed/29670043
http://dx.doi.org/10.3390/pharmaceutics10020052

Ejemplares similares